Bio-Rad Laboratories Pre-Tax Profit Margin 2006-2021 | BIO.B

Current and historical pre-tax profit margin for Bio-Rad Laboratories (BIO.B) from 2006 to 2021. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Bio-Rad Laboratories pre-tax profit margin for the three months ending September 30, 2021 was .
Bio-Rad Laboratories Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2021-09-30 $2.98B $8.56B 287.08%
2021-06-30 $2.88B $5.22B 181.15%
2021-03-31 $2.70B $5.31B 196.45%
2020-12-31 $2.55B $4.91B 192.77%
2020-09-30 $2.38B $4.53B 190.25%
2020-06-30 $2.29B $2.51B 109.37%
2020-03-31 $2.33B $2.03B 87.25%
2019-12-31 $2.31B $2.26B 97.79%
2019-09-30 $2.31B $0.52B 22.60%
2019-06-30 $2.29B $1.21B 52.69%
2019-03-31 $2.29B $0.78B 33.86%
2018-12-31 $2.29B $0.51B 22.40%
2018-09-30 $2.29B $1.60B 69.75%
2018-06-30 $2.28B $1.28B 56.11%
2018-03-31 $2.21B $0.94B 42.59%
2017-12-31 $2.16B $0.10B 4.54%
2017-09-30 $2.11B $0.02B 1.14%
2017-06-30 $2.09B $0.02B 0.77%
2017-03-31 $2.10B $0.04B 2.00%
2016-12-31 $2.07B $0.04B 2.03%
2016-09-30 $2.07B $0.12B 6.00%
2016-06-30 $2.03B $0.13B 6.21%
2016-03-31 $2.02B $0.14B 6.89%
2015-12-31 $2.02B $0.15B 7.23%
2015-09-30 $2.05B $0.14B 6.74%
2015-06-30 $2.11B $0.14B 6.40%
2015-03-31 $2.14B $0.14B 6.73%
2014-12-31 $2.18B $0.13B 6.07%
2014-09-30 $2.18B $0.13B 6.01%
2014-06-30 $2.15B $0.10B 4.83%
2014-03-31 $2.14B $0.10B 4.86%
2013-12-31 $2.13B $0.11B 5.30%
2013-09-30 $2.10B $0.13B 6.23%
2013-06-30 $2.10B $0.19B 9.10%
2013-03-31 $2.08B $0.21B 9.99%
2012-12-31 $2.07B $0.23B 11.12%
2012-09-30 $2.05B $0.25B 12.27%
2012-06-30 $2.06B $0.25B 12.22%
2012-03-31 $2.08B $0.24B 11.76%
2011-12-31 $2.07B $0.25B 11.86%
2011-09-30 $2.06B $0.22B 10.64%
2011-06-30 $2.01B $0.22B 10.98%
2011-03-31 $1.96B $0.22B 11.13%
2010-12-31 $1.93B $0.22B 11.41%
2010-09-30 $1.89B $0.21B 10.85%
2010-06-30 $1.88B $0.20B 10.54%
2010-03-31 $1.84B $0.19B 10.45%
2009-12-31 $1.78B $0.19B 10.37%
2009-09-30 $1.74B $0.15B 8.46%
2009-06-30 $1.72B $0.14B 8.09%
2009-03-31 $1.74B $0.15B 8.38%
2008-12-31 $1.76B $0.14B 8.05%
2008-09-30 $1.78B $0.15B 8.50%
2008-06-30 $1.67B $0.14B 8.54%
2008-03-31 $1.56B $0.12B 7.88%
2007-12-31 $1.46B $0.12B 8.28%
2007-09-30 $1.35B $0.13B 9.81%
2007-06-30 $1.31B $0.13B 9.85%
2007-03-31 $1.29B $0.14B 10.47%
2006-12-31 $1.27B $0.14B 11.15%
2006-09-30 $1.24B $0.13B 10.26%
2006-06-30 $1.22B $0.12B 9.54%
2006-03-31 $1.19B $0.10B 8.33%
2005-12-31 $1.18B $0.09B 7.88%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.038B $2.546B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.747B 8.96
QIAGEN (QGEN) Netherlands $10.791B 18.27
Biohaven Pharmaceutical Holding (BHVN) United States $7.896B 0.00
Emergent Biosolutions (EBS) United States $2.380B 8.56
Arcus Biosciences (RCUS) United States $2.057B 0.00
Myovant Sciences (MYOV) United Kingdom $1.157B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.011B 0.00
Zymeworks (ZYME) Canada $0.386B 0.00
Ambrx Biopharma (AMAM) United States $0.188B 0.00
SQZ Biotechnologies (SQZ) United States $0.178B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.88